体内皮肤共聚焦显微镜诊断恶性雀斑样痣谱系:多中心前瞻性研究及谱系评分提案
这项为期4年的多中心前瞻性研究纳入129处临床可疑恶性雀斑样痣(LM)皮损,用皮肤共聚焦显微镜(CCM)评估16个特征及6个LM评分特征,并对比对侧正常皮肤。结果显示CCM特征可区分LM谱系各阶段,在LM评分中加入巢状结构和真皮结构紊乱构建的LM谱系评分将LMM vs LM的AUC从0.73提高到0.95,AIMP vs良性模仿者及日光损伤皮肤的AUC从0.75提高到0.85。
要点
- CCM可辅助鉴别AIMP、LM与LMM,并指导活检定位。
- LM谱系评分较原LM评分提高诊断准确性,但需进一步验证。
- 研究限于澳大利亚人群,外推需谨慎。
核心结论
- CCM可增强LM诊断和活检指导,LM谱系评分提高准确性但需进一步验证。
研究设计与样本
- 为期4年的前瞻性多中心研究,临床可疑LM皮损接受CCM评估及后续活检/切除,共129处皮损(AIMP 28、LM 52、LMM 30、良性模仿者19)。
- 盲法专家分析16个CCM特征和6个LM评分特征,并检查对侧正常皮肤以区分AIMP与日光损伤皮肤。
- 资深专家复核CCM-病理不一致病例。
主要发现
- 关键CCM特征可区分LM谱系各阶段。
- 在LM评分中加入巢状结构和真皮结构紊乱构建LM谱系评分,提高诊断准确性。
- LMM vs LM的AUC从0.73(95% CI: 0.63, 0.84)提高到0.95(95% CI: 0.90, 0.99)。
- AIMP vs良性模仿者及日光损伤皮肤的AUC从0.75(95% CI: 0.60, 0.90)提高到0.85(95% CI: 0.76, 0.95)。
关键数值与推荐
- LM谱系评分包含原LM评分特征外加巢状结构和真皮结构紊乱。
- LMM vs LM的AUC为0.95(95% CI: 0.90, 0.99)。
- AIMP vs良性模仿者及日光损伤皮肤的AUC为0.85(95% CI: 0.76, 0.95)。
临床怎么用
- CCM可用于临床可疑LM皮损的评估,辅助区分AIMP、LM和LMM并指导活检。
- LM谱系评分可作为提高诊断准确性的工具,但需进一步外部验证。
局限性
- 数据限于澳大利亚人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Cutaneous confocal microscopy (CCM) differentiates lentigo maligna (LM) from lentigo maligna melanoma (LMM) and helps characterize atypical intraepidermal melanocytic proliferation (AIMP), a potential LM precursor. However, CCM features across the LM spectrum have not been quantitatively analyzed or prospectively validated. OBJECTIVES: To validate CCM features for AIMP, LM, and LMM, assess the Lentigo Maligna Score (LM) score's ability to distinguish early from invasive stages, and evaluate a novel diagnostic score. METHODS: In a 4-year prospective, multicentre study, clinically suspicious LM lesions underwent CCM assessment and subsequent biopsy/excision. A blinded expert analyzed 16 CCM features and 6 LM score features. Contralateral normal skin was examined to differentiate AIMP from sun-damaged skin. A senior expert reviewed CCM-pathology discordances. RESULTS: Among 129 lesions (28 AIMP, 52 LM, 30 LMM, 19 benign mimickers), key CCM features distinguished LM spectrum stages. The addition of nests and dermal architectural distortion to the LM score created the LM Spectrum Score, improving diagnostic accuracy. The area under the curve increased from 0.73 (95% CI: 0.63, 0.84) to 0.95 (95% CI: 0.90, 0.99) for LMM vs LM and from 0.75 (95% CI: 0.60, 0.90) to 0.85 (95% CI :0.76, 0.95) for AIMP vs benign mimickers and sun-damaged skin. LIMITATIONS: Data limited to Australian population. CONCLUSION: CCM enhances LM diagnosis and biopsy guidance. LM Spectrum Score improves accuracy but requires further validation.
引用
- Melhoranse Gouveia B, Wong T, Ferguson PM, et al. In vivo cutaneous confocal microscopy for diagnosing the lentigo maligna spectrum: A multicentre prospective study and proposal of a lentigo maligna spectrum score. J Am Acad Dermatol. 2025. PMID: 41161600. doi:10.1016/j.jaad.2025.10.087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。